chr5:1392909:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr5:1,392,909-1,445,555 |
| hg38 | chr5:1,392,794-1,445,440 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| <0.001 | CNS disorder | NA | BeFree | Detail | |
| 0.003 | cocaine abuse | NA | BeFree,GAD | Detail | |
| 0.007 | Delirium | NA | BeFree,GAD | Detail | |
| 0.003 | delusional disorder | NA | BeFree,GAD | Detail | |
| <0.001 | Presenile dementia | NA | BeFree | Detail | |
| 0.024 | Mental Depression | Serotonin transporter (SERT) and dopamine transporter (DAT) levels differ in pat... | BeFree,GAD | 24439516 | Detail |
| 0.002 | depressive disorder | NA | BeFree | Detail | |
| <0.001 | Disruptive Behavior Disorder | NA | BeFree | Detail | |
| 0.002 | Drug abuse | NA | BeFree | Detail | |
| 0.002 | drug allergy | NA | GAD | Detail | |
| <0.001 | Dwarfism | NA | BeFree | Detail | |
| 0.001 | Dyskinetic syndrome | NA | BeFree | Detail | |
| 0.003 | Eating Disorders | NA | BeFree,GAD | Detail | |
| <0.001 | Extrapyramidal Disorders | NA | BeFree | Detail | |
| 0.003 | fibromyalgia | NA | BeFree,GAD | Detail | |
| 0.080 | Glioma | NA | RGD | Detail | |
| 0.002 | Growth Disorders | NA | GAD | Detail | |
| <0.001 | Hallervorden-Spatz Syndrome | NA | BeFree | Detail | |
| 0.002 | Headache | NA | GAD | Detail | |
| 0.006 | heroin dependence | NA | BeFree,GAD | Detail | |
| <0.001 | HIV Infections | A short review on the relation between the dopamine transporter 10/10-repeat all... | BeFree | 24696011 | Detail |
| <0.001 | HIV Infections | Sensitivity of DAT (ITMA-DAT) was high in Sudan (94%) and India (92.3%) but low ... | BeFree | 25734336 | Detail |
| 0.003 | Hypersensitivity | NA | LHGDN | Detail | |
| 0.080 | Hypertensive disease | NA | RGD | Detail | |
| <0.001 | Kidney Failure, Chronic | Haplotype analysis showed that DAA and DAT haplotypes were risk factors for ESRD... | BeFree | 23477970 | Detail |
| 0.003 | Leukodystrophy, Metachromatic | NA | LHGDN | Detail | |
| 0.002 | Liver Cirrhosis, Alcoholic | NA | GAD | Detail | |
| 0.002 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
| 0.002 | Lymphoma, Non-Hodgkin | NA | GAD | Detail | |
| <0.001 | Machado-Joseph disease | NA | BeFree | Detail | |
| 0.002 | Marijuana Abuse | NA | GAD | Detail | |
| 0.120 | Memory Disorders | NA | CTD_human | Detail | |
| <0.001 | Movement Disorders | NA | BeFree | Detail | |
| 0.120 | Nerve Degeneration | NA | CTD_human | Detail | |
| 0.120 | nervous system disorder | NA | BeFree,CTD_human | Detail | |
| <0.001 | neuroblastoma | NA | BeFree | Detail | |
| 0.001 | nicotine dependence | Genetic influence of dopamine receptor, dopamine transporter, and nicotine metab... | BeFree | 25526961 | Detail |
| 0.006 | obesity | Association of VNTR polymorphisms in DRD4, 5-HTT and DAT1 genes with obesity. | BeFree,GAD | 25687785 | Detail |
| 0.083 | obsessive-compulsive disorder | NA | BeFree,GAD,MGD | Detail | |
| 0.002 | opioid abuse | NA | GAD | Detail | |
| <0.001 | oppositional defiant disorder | NA | BeFree | Detail | |
| <0.001 | osteochondritis dissecans | NA | BeFree | Detail | |
| 0.163 | Parkinson disease | The clinical diagnosis of Parkinson's Disease (PD) is not supported by Single Ph... | BeFree,CTD_human,GAD,LHGDN | 25182701 | Detail |
| 0.163 | Parkinson disease | These two with abnormal DAT imaging had a PD phenotype, while the remaining thre... | BeFree,CTD_human,GAD,LHGDN | 25634433 | Detail |
| 0.163 | Parkinson disease | Polymorphism of the dopamine transporter type 1 gene modifies the treatment resp... | BeFree,CTD_human,GAD,LHGDN | 25805645 | Detail |
| 0.163 | Parkinson disease | Here we show that SNCA transcripts in circulating blood cells are paradoxically ... | BeFree,CTD_human,GAD,LHGDN | 26220939 | Detail |
| 0.163 | Parkinson disease | Rs1109303 (T>G) variant within the INPP5K gene on chromosome 17p13.3 demonstrate... | BeFree,CTD_human,GAD,LHGDN | 26284320 | Detail |
| 0.005 | Perceptual Disorders | NA | GAD | Detail | |
| <0.001 | Phobia, Social | NA | BeFree | Detail | |
| <0.001 | Pituitary Diseases | NA | BeFree | Detail | |
| <0.001 | premature ejaculation | NA | BeFree | Detail | |
| 0.005 | Prenatal Exposure Delayed Effects | NA | GAD | Detail | |
| 0.002 | Psychoses, Alcoholic | NA | GAD | Detail | |
| 0.122 | Psychoses, Substance-Induced | NA | CTD_human,GAD | Detail | |
| 0.006 | Psychotic Disorders | NA | BeFree,GAD | Detail | |
| <0.001 | Respiratory Tract Infections | NA | BeFree | Detail | |
| 0.265 | schizophrenia | No association of SLC6A3 and SLC6A4 gene polymorphisms with schizophrenia in the... | BeFree,CTD_human,GAD,LHGDN,MGD | 25019689 | Detail |
| 0.001 | Seizures | NA | BeFree | Detail | |
| <0.001 | Shy-Drager Syndrome | NA | BeFree | Detail | |
| <0.001 | stereotypic movement disorder | NA | BeFree | Detail | |
| 0.004 | post-traumatic stress disorder | NA | BeFree,GAD | Detail | |
| 0.003 | Stress Disorders, Traumatic | NA | LHGDN | Detail | |
| 0.005 | stuttering | We proposed that stuttering candidate genes, DRD2 and SLC6A3, might be associate... | BeFree,GAD | 25178928 | Detail |
| <0.001 | substance dependence | Due to the mechanism of action of the dopamine transporter (DAT) in drug addicti... | BeFree | 25247548 | Detail |
| <0.001 | Substance Use Disorders | NA | BeFree | Detail | |
| 0.003 | sudden infant death syndrome | NA | BeFree,GAD | Detail | |
| 0.120 | tic disorder | NA | CTD_human | Detail | |
| 0.007 | Tobacco use disorder | NA | GAD | Detail | |
| 0.094 | Gilles de la Tourette syndrome | NA | BeFree,GAD,LHGDN,MGD | Detail | |
| <0.001 | Uncomplicated alcohol withdrawal | NA | BeFree | Detail | |
| 0.003 | Attention Deficit Disorder | NA | BeFree,GAD | Detail | |
| 0.001 | Unipolar Depression | The aim of this study was to examine the availabilities of midbrain SERT and str... | BeFree | 24439516 | Detail |
| <0.001 | Violence | NA | BeFree | Detail | |
| 0.002 | Weight Gain | NA | GAD | Detail | |
| 0.009 | Alcohol abuse | NA | GAD | Detail | |
| <0.001 | Depressive Symptoms | NA | BeFree | Detail | |
| <0.001 | Withdrawal Symptoms | NA | BeFree | Detail | |
| 0.001 | conduct disorder | NA | BeFree | Detail | |
| 0.006 | Migraine Disorders | NA | BeFree,GAD | Detail | |
| 0.003 | lingual-facial-buccal dyskinesia | NA | BeFree,GAD | Detail | |
| 0.003 | migraine with aura | NA | BeFree,GAD | Detail | |
| <0.001 | Angelman syndrome | NA | BeFree | Detail | |
| <0.001 | Chronic schizophrenia | NA | BeFree | Detail | |
| <0.001 | Psychological symptom | NA | BeFree | Detail | |
| <0.001 | Antisocial behavior | NA | BeFree | Detail | |
| <0.001 | Hallucinations, Auditory | NA | BeFree | Detail | |
| <0.001 | Hallucinations, Visual | NA | BeFree | Detail | |
| 0.005 | Personality Traits | NA | GAD | Detail | |
| 0.001 | Extrapyramidal sign | NA | BeFree | Detail | |
| <0.001 | Ataxic | NA | BeFree | Detail | |
| 0.010 | Alcohol withdrawal syndrome | NA | BeFree,GAD | Detail | |
| 0.120 | Amphetamine-Related Disorders | NA | CTD_human | Detail | |
| 0.125 | Cocaine-Related Disorders | NA | CTD_human,GAD | Detail | |
| <0.001 | Amphetamine Addiction | The dopamine transporter gene may not contribute to susceptibility and the speci... | BeFree | 25683821 | Detail |
| 0.005 | Substance-Related Disorders | NA | GAD | Detail | |
| <0.001 | Alcohol or Other Drugs use | NA | BeFree | Detail | |
| 0.002 | Physiological Sexual Disorders | NA | GAD | Detail | |
| <0.001 | Xanthomatosis, Cerebrotendinous | NA | BeFree | Detail | |
| <0.001 | Erectile dysfunction | NA | BeFree | Detail | |
| 0.012 | Malignant neoplasm of lung | NA | BeFree,GAD | Detail | |
| 0.084 | Parkinsonian Disorders | NA | BeFree,RGD | Detail | |
| <0.001 | anxiety generalized | NA | BeFree | Detail | |
| <0.001 | Severe major depression with psychotic features | NA | BeFree | Detail | |
| <0.001 | generalized anxiety disorder | Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in g... | BeFree | 24723432 | Detail |
| <0.001 | Warm autoimmune hemolytic anemia | NA | BeFree | Detail | |
| <0.001 | Expressed Emotion | The differential susceptibility theory was examined by investigating the presenc... | BeFree | 24929324 | Detail |
| 0.002 | Atrophic | NA | GAD | Detail | |
| <0.001 | Impaired cognition | NA | BeFree | Detail | |
| <0.001 | Manic | NA | BeFree | Detail | |
| <0.001 | Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type | NA | BeFree | Detail | |
| <0.001 | Nonorganic psychosis | NA | BeFree | Detail | |
| <0.001 | multiple system atrophy | NA | BeFree | Detail | |
| <0.001 | Dystonia, Diurnal | These two with abnormal DAT imaging had a PD phenotype, while the remaining thre... | BeFree | 25634433 | Detail |
| 0.002 | Inattention | NA | BeFree | Detail | |
| 0.122 | Hyperactive behavior | NA | CTD_human,GAD | Detail | |
| <0.001 | Motor symptoms | The SLC6A3 variants were also associated with greater efficacy of methylphenidat... | BeFree | 25805645 | Detail |
| 0.002 | Disruptive Behavior | NA | GAD | Detail | |
| <0.001 | dyslexia | We proposed that stuttering candidate genes, DRD2 and SLC6A3, might be associate... | BeFree | 25178928 | Detail |
| 0.121 | dementia | NA | BeFree,CTD_human | Detail | |
| <0.001 | Overweight | NA | BeFree | Detail | |
| <0.001 | Neurodegenerative Disorders | NA | BeFree | Detail | |
| <0.001 | Mood Disorders | NA | BeFree | Detail | |
| 0.003 | Alcohol Withdrawal Seizures | NA | BeFree,GAD | Detail | |
| 0.124 | Anxiety Disorders | Interaction between BDNF Val66Met and dopamine transporter gene variation influe... | BeFree | 17392738 | Detail |
| <0.001 | Violence | The objective of the present study was to identify, in a case-control study, whe... | BeFree | 21491204 | Detail |
| 0.005 | Heroin Abuse | NA | GAD | Detail | |
| 0.001 | cocaine dependence | NA | BeFree | Detail | |
| <0.001 | Emotional problems | NA | BeFree | Detail | |
| <0.001 | Carcinoma of lung | NA | BeFree | Detail | |
| <0.001 | Tardive Dyskinesia | NA | BeFree | Detail | |
| <0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Substance abuse problem | NA | BeFree | Detail | |
| <0.001 | Depression, psychotic | NA | BeFree | Detail | |
| <0.001 | spinocerebellar ataxia type 2 | NA | BeFree | Detail | |
| <0.001 | Chronic Daily Headache | NA | BeFree | Detail | |
| 0.003 | Lewy Body Disease | NA | BeFree,LHGDN | Detail | |
| <0.001 | Schizophrenia and related disorders | NA | BeFree | Detail | |
| <0.001 | bipolar I disorder | NA | BeFree | Detail | |
| 0.002 | Appetite suppression (finding) | NA | GAD | Detail | |
| <0.001 | Psychotic symptom | NA | BeFree | Detail | |
| 0.002 | traumatic brain injury | NA | GAD | Detail | |
| <0.001 | Developmental reading disorder | Stuttering candidate genes DRD2 but not SLC6A3 is associated with developmental ... | BeFree | 25178928 | Detail |
| 0.003 | Malignant neoplasm of ovary | NA | BeFree,GAD | Detail | |
| 0.004 | major depressive disorder | The aim of this study was to examine the availabilities of midbrain SERT and str... | BeFree,GAD | 24439516 | Detail |
| <0.001 | autoimmune lymphoproliferative syndrome | NA | BeFree | Detail | |
| <0.001 | Attention deficit-hyperactivity | NA | BeFree | Detail | |
| 0.120 | Micronuclei, Chromosome-Defective | NA | CTD_human | Detail | |
| 0.005 | Methamphetamine abuse | NA | GAD | Detail | |
| 0.120 | Paranoia | NA | BeFree,CTD_human | Detail | |
| <0.001 | drug dependence | Due to the mechanism of action of the dopamine transporter (DAT) in drug addicti... | BeFree | 25247548 | Detail |
| <0.001 | MAJOR AFFECTIVE DISORDER 2 | NA | BeFree | Detail | |
| <0.001 | NEUROTICISM | Further analyses showed that the DAT availability was correlated with the neurot... | BeFree | 25001970 | Detail |
| <0.001 | Dopa-responsive dystonia | These two with abnormal DAT imaging had a PD phenotype, while the remaining thre... | BeFree | 25634433 | Detail |
| <0.001 | DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT | NA | BeFree | Detail | |
| 0.121 | MAJOR AFFECTIVE DISORDER 1 | NA | BeFree,CTD_human | Detail | |
| 0.120 | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | NA | CTD_human | Detail | |
| <0.001 | AMYOTROPHIC LATERAL SCLEROSIS 1 | NA | BeFree | Detail | |
| <0.001 | MAJOR AFFECTIVE DISORDER 4 | NA | BeFree | Detail | |
| <0.001 | MAJOR AFFECTIVE DISORDER 5 | NA | BeFree | Detail | |
| <0.001 | MAJOR AFFECTIVE DISORDER 6 | NA | BeFree | Detail | |
| <0.001 | bulimia nervosa | NA | BeFree | Detail | |
| <0.001 | DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE (disorder) | NA | BeFree | Detail | |
| <0.001 | Major affective disorder 7 | NA | BeFree | Detail | |
| <0.001 | MAJOR AFFECTIVE DISORDER 8 | NA | BeFree | Detail | |
| <0.001 | MAJOR AFFECTIVE DISORDER 9 | NA | BeFree | Detail | |
| <0.001 | Executive dysfunction | NA | BeFree | Detail | |
| 0.002 | Weight Gain Adverse Event | NA | GAD | Detail | |
| 0.002 | Finding relating to sexuality and sexual activity | NA | GAD | Detail | |
| <0.001 | Undifferentiated attention deficit disorder | NA | BeFree | Detail | |
| 0.002 | Opium abuse | NA | GAD | Detail | |
| 0.004 | Alcohol Withdrawal Delirium | NA | BeFree,GAD | Detail | |
| 0.035 | Alcoholic Intoxication, Chronic | The present study aimed to evaluate the association of alcohol dependence and al... | BeFree,GAD | 25035107 | Detail |
| 0.035 | Alcoholic Intoxication, Chronic | Association study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A polymorphisms wi... | BeFree,GAD | 25684044 | Detail |
| 0.035 | Alcoholic Intoxication, Chronic | A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associ... | BeFree,GAD | 26058807 | Detail |
| 0.011 | Alzheimer's disease | Abnormal expression and genetic polymorphism of SLC6A3 and SLC6A4 genes may incr... | BeFree,GAD,LHGDN | 25019689 | Detail |
| 0.011 | Alzheimer's disease | Association between the 9 repeat allele of the dopamine transporter 40bp variabl... | BeFree,GAD,LHGDN | 25130782 | Detail |
| 0.011 | Alzheimer's disease | Sensitivity of DAT (ITMA-DAT) was high in Sudan (94%) and India (92.3%) but low ... | BeFree,GAD,LHGDN | 25734336 | Detail |
| <0.001 | amyotrophic lateral sclerosis | NA | BeFree | Detail | |
| <0.001 | Anemia, Hemolytic | NA | BeFree | Detail | |
| <0.001 | anorexia nervosa | NA | BeFree | Detail | |
| 0.002 | antisocial personality disorder | NA | GAD | Detail | |
| 0.002 | Anxiety | NA | GAD | Detail | |
| 0.124 | Anxiety Disorders | NA | BeFree,CTD_human,GAD | Detail | |
| 0.017 | As If Personality | NA | GAD | Detail | |
| <0.001 | Ataxia | NA | BeFree | Detail | |
| 0.002 | Behavior Disorders | NA | GAD | Detail | |
| 0.002 | Malignant neoplasm of urinary bladder | NA | GAD | Detail | |
| 0.002 | Malignant neoplasm of breast | NA | GAD | Detail | |
| 0.003 | Bulimia | NA | BeFree,GAD | Detail | |
| <0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Serotonin transporter (SERT) and dopamine transporter (DAT) levels differ in patients with major dep... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| A short review on the relation between the dopamine transporter 10/10-repeat allele and ADHD: implic... | DisGeNET | Detail |
| Sensitivity of DAT (ITMA-DAT) was high in Sudan (94%) and India (92.3%) but low in France being 88.5... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Haplotype analysis showed that DAA and DAT haplotypes were risk factors for ESRD. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking ces... | DisGeNET | Detail |
| Association of VNTR polymorphisms in DRD4, 5-HTT and DAT1 genes with obesity. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The clinical diagnosis of Parkinson's Disease (PD) is not supported by Single Photon Emission Comput... | DisGeNET | Detail |
| These two with abnormal DAT imaging had a PD phenotype, while the remaining three subjects with the ... | DisGeNET | Detail |
| Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's ... | DisGeNET | Detail |
| Here we show that SNCA transcripts in circulating blood cells are paradoxically reduced in early sta... | DisGeNET | Detail |
| Rs1109303 (T>G) variant within the INPP5K gene on chromosome 17p13.3 demonstrated a genome-wide sign... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| No association of SLC6A3 and SLC6A4 gene polymorphisms with schizophrenia in the Han Chinese populat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We proposed that stuttering candidate genes, DRD2 and SLC6A3, might be associated with dyslexia. | DisGeNET | Detail |
| Due to the mechanism of action of the dopamine transporter (DAT) in drug addiction, the DAT1 gene is... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The aim of this study was to examine the availabilities of midbrain SERT and striatal DAT in healthy... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The dopamine transporter gene may not contribute to susceptibility and the specific personality trai... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety d... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The differential susceptibility theory was examined by investigating the presence of interaction eff... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These two with abnormal DAT imaging had a PD phenotype, while the remaining three subjects with the ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The SLC6A3 variants were also associated with greater efficacy of methylphenidate for motor symptoms... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We proposed that stuttering candidate genes, DRD2 and SLC6A3, might be associated with dyslexia. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related... | DisGeNET | Detail |
| The objective of the present study was to identify, in a case-control study, whether the brain-deriv... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Stuttering candidate genes DRD2 but not SLC6A3 is associated with developmental dyslexia in Chinese ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The aim of this study was to examine the availabilities of midbrain SERT and striatal DAT in healthy... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Due to the mechanism of action of the dopamine transporter (DAT) in drug addiction, the DAT1 gene is... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Further analyses showed that the DAT availability was correlated with the neuroticism score only in ... | DisGeNET | Detail |
| These two with abnormal DAT imaging had a PD phenotype, while the remaining three subjects with the ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The present study aimed to evaluate the association of alcohol dependence and alcohol dependence-rel... | DisGeNET | Detail |
| Association study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A polymorphisms with alcohol dependenc... | DisGeNET | Detail |
| A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but n... | DisGeNET | Detail |
| Abnormal expression and genetic polymorphism of SLC6A3 and SLC6A4 genes may increase the risk of dev... | DisGeNET | Detail |
| Association between the 9 repeat allele of the dopamine transporter 40bp variable tandem repeat poly... | DisGeNET | Detail |
| Sensitivity of DAT (ITMA-DAT) was high in Sudan (94%) and India (92.3%) but low in France being 88.5... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386602118 dbSNP
- Genome
- hg19
- Position
- chr5:1,392,909-1,445,555
- Variant Type
- snv
Genome browser